Does Rallies show Form 4 insider transactions for CBLL?

Yes. Rallies tracks CBLL insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is CBLL research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CBLL. It does not provide personalized investment advice.

CBLL (CeriBell, Inc. Common Stock) Stock Analysis - Insider Trades

CeriBell, Inc. Common Stock (CBLL) is a publicly traded Healthcare sector company. As of May 20, 2026, CBLL trades at $18.11 with a market cap of $629.09M and a P/E ratio of -12.18. CBLL moved +6.66% today. Year to date, CBLL is -13.02%; over the trailing twelve months it is -0.44%. Its 52-week range spans $10.01 to $32.75. Analyst consensus is strong buy with an average price target of $28.50. Rallies surfaces CBLL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading CBLL stock inside the company?

Recent CBLL insider activity includes Chao Xingjuan sold 14.00K, Chao Xingjuan sold 1.45K, Chao Xingjuan sold 23.55K, Woo Raymond sold 1.47K, and Woo Raymond sold 3.02K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

CBLL Key Metrics

Key financial metrics for CBLL
Metric	Value
Price	$18.11
Market Cap	$629.09M
P/E Ratio	-12.18
EPS	$-1.46
Dividend Yield	0.00%
52-Week High	$32.75
52-Week Low	$10.01
Volume	303.61K
Avg Volume	0
Revenue (TTM)	$89.06M
Net Income	$-53.41M
Gross Margin	87.89%

Recent CBLL Insider Trades

Chao Xingjuan sold 14.00K (~$281.68K) on May 5, 2026.
Chao Xingjuan sold 1.45K (~$29.09K) on May 5, 2026.
Chao Xingjuan sold 23.55K (~$473.20K) on May 5, 2026.
Woo Raymond sold 1.47K (~$29.95K) on May 1, 2026.
Woo Raymond sold 3.02K (~$61.78K) on May 1, 2026.

Latest CBLL News

CeriBell Grows Revenue 36% to $89M, Expands EEG Platform into Pediatrics and Delirium — Mar 7, 2026
CeriBell Q4 Sales Jump 34% to $24.8M While Price Target Cut to $28 — Mar 2, 2026
Ceribell’s Q4 Revenue Soars 34% to $24.8M; FDA Clears Neonatal and Delirium Devices — Feb 24, 2026

CBLL Analyst Consensus

6 analysts cover CBLL: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $28.50.

Common questions about CBLL

Who is trading CBLL stock inside the company?: Recent CBLL insider activity includes Chao Xingjuan sold 14.00K, Chao Xingjuan sold 1.45K, Chao Xingjuan sold 23.55K, Woo Raymond sold 1.47K, and Woo Raymond sold 3.02K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CBLL?: Yes. Rallies tracks CBLL insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CBLL research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CBLL. It does not provide personalized investment advice.